Patent ID: 11957696
Assignee: PROPELLA THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 11:
12. The method of claim 1, further comprising administering to the subject (1) a poly ADP ribose polymerase (PARP) inhibitor; (2) a 1st-generation androgen receptor antagonist; (3) a 2nd-generation androgen receptor antagonist; (4) a 3rd generation androgen receptor antagonist or an androgen receptor degrader molecule, alone or in combination with one or more 1st generation or 2nd generation androgen receptor antagonists; (5) a chemotherapeutic agent; (6) an immunotherapy; (7) a bispecific T-cell engager (BiTE) therapy; and/or (8) a kinase inhibitor.